Arrow Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Arrow Capital's PFE Position: Q4 2025 in Review
Arrow Capital sold out of Pfizer (PFE) in Q4 2025, closing a stake of 250,000 shares — an estimated $9.63M sold.
Arrow Capital first reported a position in PFE in Q4 2024 and held it in 3 quarters. The position peaked at $9.63M in Q3 2025. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Arrow Capital reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Arrow Capital sold 250,000 Pfizer shares in Q4 2025, an estimated $9.63M.
- Arrow Capital first reported a position in Pfizer in Q4 2024 and held it in 3 quarters.
- Arrow Capital's Pfizer position peaked at $9.63M in Q3 2025.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Arrow Capital's 13F filing for Q4 2025, filed 17 Feb 2026.